The owner of Hong Kong’s benchmark Hang Seng stock index has launched two indices, one for the nascent metaverse and another for genomics and oncology.
The Hang Seng China Metaverse Index includes virtual reality (VR), gaming and other digital experiences that use advanced technology in virtual spaces.
Hang Seng Indexes said the metaverse “has captured the attention of people around the world” and such companies are rapidly growing in popularity as investment themes among investors.
The Metaverse Index aims to reflect the performance of mainland China companies that are involved in metaverse-related business, value chains and development.
The Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index will track companies involved in genomic medicine and innovative drugs developed as mainstream treatments for cancer and other diseases.
Research and Development
The index aims to track the performance of companies that are involved in the research and development of genomics or oncology-related products and services.
“New megatrends are having an increasingly significant impact on our daily lives,” said Daniel Wong, director and chief index officer at Hang Seng Indexes.
“Our two new megatrend indexes are designed to help investors capture potential opportunities arising from these innovative and transformative trends in the mainland China and Hong Kong stock markets.”
The index universe for each of the two indexes covers stocks listed in Shanghai, Shenzhen and Hong Kong.
“The two new indexes are calculated and disseminated in real-time at two-second intervals,” Wong added.
- George Russell
READ MORE:
Sony Ready for Metaverse Revolution Across Platforms
Meta Inks Deal for 3D Ads as it Advances into Metaverse
Second Life Creator Says Facebook-like Metaverse a Disaster – Nikkei
